On May 22 and June 12 WHO CC Latvia in collaboration with Latvian Society against Tuberculosis and partners from TB community hosted two webinars as a part of 4th Baltic Symposium for TB clinicians and laboratory staff to introduce the updates from the WHO consolidated guidelines and the latest evidence and recommendation for diagnosis, treatment and management of TB during COVID-19 epidemic.
First TB webinar was organized on May 22 and gathered more than 160 participants. During the webinar participants were introduced with the updates in TB preventive treatment; WHO approach to the people centered delivery of TB prevention, diagnosis, treatment and care during the COVID-19 pandemic; current evidence and lessons learned on COVID-19 and TB; as well as the challenges to reach the EndTB strategy goals.
Second TB webinar was organized on June 12 and the agenda included the key changes in treatment of drug-resistant TB, highlights from the forthcoming WHO consolidated TB guidelines, supporting activities of WHO EURO on laboratory diagnosis and MDR-TB during and beyond COVID-19 pandemic, as well as the evidence to date on trials of treatment for M/XDR-TB. More than 169 participants connected to the webinar.
TB clinicians, laboratory staff and other public healthcare staff involved in TB patients care
English with simultaneous interpretation into Russian
These events were financially supported by Johnson & Johnson and Otsuka Novel Products GmbH